arrow
J

Jason N. Berman

University of Ottawa and Children's Hospital of Eastern Ontario Research Institute
H指数:38
被引数:4,870

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease

分子风险标志物定义唐氏综合征髓系白血病的复发风险,超越可测残留病灶

2025-10-240
OAAI
Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe

蛋白质组学和个性化PDX模型识别出在可操作时间框架内针对进展性恶性肿瘤的治疗方案

2025-04-010
OA
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Treatment Intensification Does Not Improve Outcome for Children with Myeloid Leukemia of Down Syndrome

治疗强化并未改善唐氏综合征伴髓系白血病患儿的预后

BLOOD
IF23.1
2024-11-050
PRE
Targeting Metabolism to Restore Hematopoiesis in Inherited Bone Marrow Failure Syndromes: Preclinical Insights from Zebrafish Models

靶向代谢以恢复遗传性骨髓衰竭综合征中的造血功能:来自斑马鱼模型的临床前见解

BLOOD
IF23.1
2024-11-050
PRE
CIAO1 and MMS19 de fi ciency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders
2024-06-012
OAAI
Prioritizing treatment targets for an adolescent with metastatic processive malignancy using proteomics and personalized xenograft models within an actionable timeframe
2024-03-220
PRE
A pan-Canadian precision oncology program for children, adolescents and young adults with hard-to-cure cancer: The PRecision Oncology For Young peopLE (PROFYLE) Program
2023-04-042
PRE
Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation
2022-12-228
OA